Added to YB: 2022-12-01
Pitch date: 2022-12-01
HLS. [bullish]
HLS Therapeutics Inc.
-49.65%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally.
Market Cap
CAD 95.5M
Pitch Price
CAD 9.91
Price Target
N/A
Dividend
N/A
EV/EBITDA
9.61
P/E
-4.84
EV/Sales
2.55
Sector
Pharmaceuticals
Category
N/A
Show full summary:
HLS THERAPEUTICS INC HLS.
A summary for this pitch has not been created yet.
Read full article (0 min)